$HUN

Huntsman Corporation Stock 12‑Month Price Target Cut to $10.94, Implies 27% Upside

Huntsman Corporation's average stock price target was reduced from $11 to $10.94 by 16 analysts, with forecasts ranging from $9 to $15. This implies a 27% upside from the Oct. 16 closing price. The consensus rating remains 'Hold' among 19 analysts, with 4 'Buy', 13 'Hold', and 2 'Sell' ratings.

Original reporting
Published Oct 19, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 4:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Huntsman Corporation Stock 12‑Month Price Target Cut to $10.94, Implies 27% Upside — source image
Decision brief

The 30-second read

$HUNBearishLow
01

Why it matters

The target reduction may trigger short-term selling pressure, but the still‑high implied upside could support a rebound if new positive news emerges.

02

Market read

Analyst target change provides modest trading signal for HUN shareholders and short‑term traders.

03

What to watch

Potential hidden catalysts such as upcoming contract wins or cost reductions not reflected in the target.

Relevance 5/10Novelty 4/10Timing: today

Background

Huntsman Corporation is a US-listed specialty chemicals producer (NYSE: HUN). The article reports a recent analyst consensus price target adjustment.

Company-level read

Ticker impact

$HUNBearishMedium confidence
Context

Analyst consensus price target lowered to $10.94, down from $11, indicating a fresh downgrade in expectations.

Expected impact

likely pressure as market prices in the lower target

Evidence & confidence

Analyst price target reductions typically lead to short-term sell pressure, even if upside remains.

Market effects

Minor impact on specialty chemicals sector as peers may see similar target revisions.

Limited to US-listed specialty chemicals investors.

Low global relevance.

Counterpoint

Despite the target cut, the implied 27% upside may attract value buyers.

Key entities

  • Huntsman Corporation

    Specialty chemicals manufacturer

Related articles

$HUNMed

Jefferies cuts Huntsman stock price target on European challenges

Jefferies reduced its price target for Huntsman Corp. (NYSE:HUN) to $11 from $16, citing European challenges but maintaining a Buy rating. The stock trades at $8.57, with potential upside. Huntsman's Q3 outlook is supported by industrial activity, but Europe faces gas costs and soft demand. The company expects $400M in synergies from its Olin merger. Q2 2026 earnings beat expectations, with revenue at $1.66B and adjusted EPS at $0.20.

$OLNHighAI 9/10

Olin, Huntsman Merger of Equals Clears U.S. Antitrust Hurdle

Olin (OLN) and Huntsman (HUN) cleared a U.S. antitrust hurdle for their all-stock merger, expected to create a $12.5B chemicals company with $400M in cost synergies. The deal, targeting 1H 2027 completion, still needs regulatory approvals. OLN shares fell 32.2% and HUN dropped 8.6% over the past year.

$OLNHighAI 9/10

Olin and Huntsman merger clears antitrust waiting period

Olin (OLN) and Huntsman (HUN) cleared the U.S. antitrust waiting period for their proposed merger. The milestone satisfies one closing condition, but additional regulatory approvals and customary closing conditions are still required. Olin is a chemical manufacturer and ammunition producer, while Huntsman is a diversified chemicals company with $6B in 2025 revenue.

$OLNMedAI 9/10

Olin Corporation; Huntsman Corporation: OLIN and HUNTSMAN Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger

Olin (OLN) and Huntsman (HUN) announced the expiration of the HSR Act waiting period for their proposed merger, satisfying a key closing condition. Shareholders approved the transaction, but regulatory approvals are still required. Olin is a chemical and ammunition manufacturer, while Huntsman is a diversified chemical producer with 2025 revenues of $6 billion.